OBJECTIVE: To determine the effect of transfusion on hematologic recovery and mortality among severely anemic children during and after hospitalization in rural Kenya. DESIGN: Prospective cohort. METHODS: We collected clinical and laboratory information on all severely anemic children (hemoglobin < 5.0 g/dl) and a 33% sample of children with hemoglobin < or = 5.0 g/dl who were admitted to the pediatric ward of a rural Kenyan hospital during a 6 month study period. Children were followed during hospitalization and at 4 and 8 weeks after admission. RESULTS: Overall, 303 (25%) of the 1223 hospitalized children had hemoglobin < 5.0 g/dl, 30% of whom died during the study period. Severely anemic children who were transfused had a higher mean hemoglobin level at discharge (9.0 g/dl) than non-transfused children (5.8 g/dl, P < 0.001) and maintained a higher mean hemoglobin during the 8-week follow-up period. However, the presence of malaria parasitemia on follow-up negated the benefit of transfusion on hematologic recovery at both 4- and 8-week visits (longitudinal linear model, least square means, P > 0.05). Transfusion was associated with improved survival among children with respiratory distress who received transfusions within the first 2 days of hospitalization. CONCLUSIONS: The use of transfusion can be improved by targeting use of blood to severely anemic children with cardiorespiratory compromise, improving immediate availability of blood, and treating severely anemic children with effective antimalarial therapy.
OBJECTIVE: To determine the effect of transfusion on hematologic recovery and mortality among severely anemicchildren during and after hospitalization in rural Kenya. DESIGN: Prospective cohort. METHODS: We collected clinical and laboratory information on all severely anemicchildren (hemoglobin < 5.0 g/dl) and a 33% sample of children with hemoglobin < or = 5.0 g/dl who were admitted to the pediatric ward of a rural Kenyan hospital during a 6 month study period. Children were followed during hospitalization and at 4 and 8 weeks after admission. RESULTS: Overall, 303 (25%) of the 1223 hospitalized children had hemoglobin < 5.0 g/dl, 30% of whom died during the study period. Severely anemicchildren who were transfused had a higher mean hemoglobin level at discharge (9.0 g/dl) than non-transfused children (5.8 g/dl, P < 0.001) and maintained a higher mean hemoglobin during the 8-week follow-up period. However, the presence of malaria parasitemia on follow-up negated the benefit of transfusion on hematologic recovery at both 4- and 8-week visits (longitudinal linear model, least square means, P > 0.05). Transfusion was associated with improved survival among children with respiratory distress who received transfusions within the first 2 days of hospitalization. CONCLUSIONS: The use of transfusion can be improved by targeting use of blood to severely anemicchildren with cardiorespiratory compromise, improving immediate availability of blood, and treating severely anemicchildren with effective antimalarial therapy.
Entities:
Keywords:
Africa; Africa South Of The Sahara; Age Factors; Anemia--prevention and control; Blood Transfusion; Child; Child Mortality; Child Survival; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Kenya; Length Of Life; Malaria; Mortality; Parasitic Diseases; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research Methodology; Research Report; Studies; Survivorship; Treatment; Youth
Authors: S Resino; J M Bellón; S Sánchez-Ramón; D Gurbindo; J Ruiz-Contreras; J A León; J T Ramos; M A Muñóz-Fernández Journal: Arch Dis Child Date: 2002-02 Impact factor: 3.791
Authors: T Were; G C Davenport; J B Hittner; C Ouma; J M Vulule; J M Ong'echa; D J Perkins Journal: J Clin Microbiol Date: 2010-11-24 Impact factor: 5.948
Authors: Madhuradhar Chegondi; Jun Sasaki; André Raszynski; Balagangadhar R Totapally Journal: Transfus Med Hemother Date: 2016-05-23 Impact factor: 3.747
Authors: Kalifa A Bojang; Paul J M Milligan; David J Conway; Fatou Sisay-Joof; Muminatou Jallow; Davis C Nwakanma; Ismaela Abubakr; Fanta Njie; Brian Greenwood Journal: PLoS One Date: 2010-06-21 Impact factor: 3.240
Authors: Allan Doctor; Jill M Cholette; Kenneth E Remy; Andrew Argent; Jeffrey L Carson; Stacey L Valentine; Scot T Bateman; Jacques Lacroix Journal: Pediatr Crit Care Med Date: 2018-09 Impact factor: 3.624
Authors: Pierre Demaret; Guillaume Emeriaud; Nabil E Hassan; Martin C J Kneyber; Stacey L Valentine; Scot T Bateman; Marisa Tucci Journal: Pediatr Crit Care Med Date: 2018-09 Impact factor: 3.624
Authors: Stacey L Valentine; Melania M Bembea; Jennifer A Muszynski; Jill M Cholette; Allan Doctor; Phillip C Spinella; Marie E Steiner; Marisa Tucci; Nabil E Hassan; Robert I Parker; Jacques Lacroix; Andrew Argent; Jeffrey L Carson; Kenneth E Remy; Pierre Demaret; Guillaume Emeriaud; Martin C J Kneyber; Nina Guzzetta; Mark W Hall; Duncan Macrae; Oliver Karam; Robert T Russell; Paul A Stricker; Adam M Vogel; Robert C Tasker; Alexis F Turgeon; Steven M Schwartz; Ariane Willems; Cassandra D Josephson; Naomi L C Luban; Leslie E Lehmann; Simon J Stanworth; Nicole D Zantek; Timothy E Bunchman; Ira M Cheifetz; James D Fortenberry; Meghan Delaney; Leo van de Watering; Karen A Robinson; Sara Malone; Katherine M Steffen; Scot T Bateman Journal: Pediatr Crit Care Med Date: 2018-09 Impact factor: 3.624
Authors: Robert O Opoka; Karen E S Hamre; Nathan Brand; Paul Bangirana; Richard Idro; Chandy C John Journal: J Pediatric Infect Dis Soc Date: 2017-09-01 Impact factor: 3.164